A comparison of mixture cure fraction models to traditional parametric survival models in estimation of the cost-effectiveness of nivolumab for relapsed small cell lung cancer
JOURNAL OF MEDICAL ECONOMICS（2021）
Key words
Nivolumab,small cell lung cancer,cost-effectiveness,mixture cure models,QALY
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined